in Nice, a unique machine in the world to sterilize tumors related to colorectal cancer

in Nice, a unique machine in the world to sterilize tumors related to colorectal cancer


At the Antoine Lacassagne Center, a machine dramatically regresses colorectal cancer tumors. It is able to “bombard” X-rays of tumors with extreme precision, halving them in a single session.

It is a weapon that could well start the war on cancer. The management of this type of disease is constantly evolving, and it is in Nice, at Antoine Lacassagne Centerthat cutting-edge technologies help heal patients.

In the Hexagon, colorectal cancer is being screened, according to figures released by Public Health France, at 43,336 people each year, and 17,117 deaths are connected to it annually.

One National screening program is offered for both men and women over 50 years old.

It is on the treatment side that these patients will be able to turn to hope for a quick and effective cure.

“I did the first radio show, and there, the professor told me ‘it’s amazing, it’s halved’. For Abbas Faraht, who was diagnosed with colorectal cancer earlier this year, it is a real – and pleasant – surprise to have been able to see the benefits of this treatment on his disease, which he thought was fatal.

Already, the word cancerous tumor, you know it’s dangerous, there are psychological issues all of a sudden because it’s something that can be deadly if not detected in time.

Abbas Faraht

Patient with colorectal cancer

This is the device that is in the brokerage therapy room is unique in the world. It sends a massive dose of X-rays to cancerous tissues, sparing nearby healthy tissue, and to a very small area.

One European study called OPERA (for Organ Preservation in Early Rectal Adenocarcinoma or Organ Preservation in Early Rectal Adenocarcinoma in French)

“Scientific proof has just been provided by this famous randomized trial […] and it has been shown that when you do only normal rays, you have 60% success, and you go to 90% by adding 3 sessions of Butterfly apparatus. “ granted by Professor Jean-Pierre Gérard, of the Antoine Lacassagne Center.

These results were presented at the the ASCO (American Oncology Association), Chicago, USA, June 4, 2022. They demonstrate that by supplementing external radiation therapy with contact radiation therapy, this cure rate is effective in tumors less than 3 centimeters, with only these three additive sessions lasting 5 minutes each.

The Papillon 50, named after the French professor who developed this tool, brings other benefits to technology:this avoids surgery with potential functional consequences, […] and this is especially interesting in patients who are elderly, and for whom surgery would expose them to significant anesthetic and surgical risks. “ details Dr. Cyrielle Scouarnec.

All patients who were treated in the OPERA study have since been remitted.



Leave a Comment

Your email address will not be published.